Merck abandons $7M in grants for long-term IT hiring plan in AustinAllbiopro2019-07-04T09:19:37+09:007월 4th, 2019|
Pharma takes Wi-Fi targeting to the doctor’s office to reach waiting patients on their smartphonesAllbiopro2019-07-04T09:18:39+09:007월 4th, 2019|
Chutes & Ladders—Merrimack’s CEO, CFO and president abandon shipAllbiopro2019-07-04T09:17:39+09:007월 4th, 2019|
In conversation with Cydan’s Chris Adams and James McArthurAllbiopro2019-07-04T09:16:17+09:007월 4th, 2019|
Purdue hires Ducharme as CSO to aid expansion beyond opioidsAllbiopro2019-07-04T09:15:46+09:007월 4th, 2019|
FDA puts Unum T cell therapy trial on hold after adverse eventsAllbiopro2019-07-04T09:15:14+09:007월 4th, 2019|
Spark on the evolving commercial cell & gene therapy spaceAllbiopro2019-07-04T09:14:43+09:007월 4th, 2019|
Amicus Partners with Catalent on Lysosomal Disease Gene Therapy ProgramsAllbiopro2019-07-04T09:14:12+09:007월 4th, 2019|
FDA Publishes Guidance on Instructions for Use in Patient LabelingAllbiopro2019-07-04T09:13:39+09:007월 4th, 2019|
FUJIFILM Irvine Scientific constructs new cell culture media manufacturing site in EuropeAllbiopro2019-07-04T09:12:09+09:007월 4th, 2019|
To Include Commercial Manufacturing, WuXi Biologics will Expand Integrated Biologics Conjugation Solution CenterAllbiopro2019-07-03T10:01:41+09:007월 3rd, 2019|
USFDA Approval Received by Alembic Pharmaceuticals for Febuxostat Tablets, 40 mg and 80 mg.Allbiopro2019-07-03T10:01:11+09:007월 3rd, 2019|
